PUBLIC CONTRACT · 2021

Aquisição de medicamentos (não exclusivos) ao abrigo dos AQs 2017/48, 2017/6, 2018/64, 2019/40 e 2019/55, no âmbito da Agregação Centralizada 2021

Contract value
€1,425.60
Signed on
31 March 2021
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 7615664

PUBLISHED DESCRIPTION

P259-2020-167

WHO CONTRACTED

Parties involved

Place of performance
Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
MYLAN, Lda · Tax ID 502248793
Bidder
Hikma Farmacêutica (Portugal), Lda. · Tax ID 502266791
Bidder
AbbVie, LDA · Tax ID 510229050
Bidder
Accord · Tax ID 508622263
Bidder
Laboratórios Pfizer, Lda. · Tax ID 500162166
Bidder
MEDAC · Tax ID 980369959
Bidder
FRESENIUS KABI PHARMA PORTUGAL, LDA. · Tax ID 504293753
Bidder
Sandoz · Tax ID 506985261

HOW MUCH AND WHEN

Values and timeline

Contract price
€1,425.60
Procedure base price
€1,683,959.25
Total effective price
Not reported on Portal BASE
Publication date
16 April 2021
Award date
31 March 2021
Signing date
31 March 2021
Performance period
270 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2019/55 - Medicamentos diversos
Centralised procedure
Yes
Environmental criterion
No
Notice
Not stated
Procedure identifier
5051397

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts